Singer P A, Cooper D S, Levy E G, Ladenson P W, Braverman L E, Daniels G, Greenspan F S, McDougall I R, Nikolai T F
Division of Endocrinology, Diabetes, and Hypertension, University of Southern California School of Medicine, Los Angeles 90033.
JAMA. 1995 Mar 8;273(10):808-12.
To develop a set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with hyperthyroidism and hypothyroidism.
Guidelines were developed by a nine-member ad hoc Standards of Care Committee of the American Thyroid Association (the authors of this article). The participants were selected by the committee chair and the president of the American Thyroid Association on the basis of their clinical experience. The committee members represented different geographic areas within the United States, in order to take into account different practice styles.
Guidelines were developed on the basis of expert opinion of the participants, as well as on available published information.
Input was obtained from all of the participants, each of whom wrote an initial section of the document. A complete draft document was then written by three participants (P.A.S., D.S.C., and E.G.L.) and resubmitted to the entire committee for revision. The revised document was then submitted to the entire membership of the American Thyroid Association for written comments, which were then reviewed (mainly by P.A.S., D.S.C., and E.G.L.). Many of the suggestions of the American Thyroid Association members were incorporated into the final draft, which was then approved by the Executive Council of the American Thyroid Association. The entire process, from initial drafts to final approval, took approximately 18 months.
A set of minimum clinical guidelines for the diagnosis and treatment of hyperthyroidism and hypothyroidism were developed by consensus of a group of experienced thyroidologists. The guidelines are intended to be used by physicians in their care of patients with thyroid disorders, with the expectation that more effective care can be provided, and at a cost savings.
制定一套基层医疗医生用于评估和管理甲状腺功能亢进和甲状腺功能减退患者的最低临床指南。
指南由美国甲状腺协会一个由九名成员组成的临时护理标准委员会（本文作者）制定。参与者由委员会主席和美国甲状腺协会主席根据他们的临床经验挑选。委员会成员代表美国不同地理区域，以考虑不同的执业风格。
指南基于参与者的专家意见以及现有已发表信息制定。
从所有参与者那里获取意见，他们每人撰写了文件的初始部分。然后由三名参与者（P.A.S.、D.S.C.和E.G.L.）撰写了完整的文件草案，并重新提交给整个委员会进行修订。修订后的文件随后提交给美国甲状腺协会全体成员征求书面意见，然后进行审查（主要由P.A.S.、D.S.C.和E.G.L.进行）。美国甲状腺协会成员的许多建议被纳入最终草案，最终草案随后获得美国甲状腺协会执行委员会的批准。从初稿到最终批准的整个过程耗时约18个月。
一组有经验的甲状腺专家通过共识制定了一套用于甲状腺功能亢进和甲状腺功能减退诊断和治疗的最低临床指南。这些指南旨在供医生在治疗甲状腺疾病患者时使用，期望能提供更有效的治疗并节省成本。
